Skip to main content
Caplight Logo









Luminopia, Inc.

Luminopia, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.luminopia.com/

Last Round

Series A

Jun 27, 2023

Total Funding Raised

$22.65M

Company Overview

Luminopia, Inc. is a digital health company that provides an FDA-cleared, prescription-only virtual reality therapy for amblyopia (lazy eye) in children.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Experiences, Patient Engagement

Business Model

B2B2C

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Non-AI

Keywords

digital therapeuticsDTxamblyopia treatmentlazy eye therapysoftware as a medical deviceSaMDVR therapyvirtual reality healthcarebinocular visionpediatric ophthalmologyprescription digital therapeuticspatient adherencedichoptic trainingeye care technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminopia, Inc. Comparables

Compare Luminopia, Inc. with similar companies based on industry and business-model similarity.

Luminopia, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NovaSight
86%
Vivid Vision
84%
Bynocs
81%

Luminopia, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 27, 2023
SeedNov 11, 2022
AngelFeb 1, 2017

Key People

Founding team and executive leadership

Scott Xiao

Co-Founder And CEO

Founding Team

Luminopia, Inc. Investors

Notable investors and investment history

Luminopia, Inc. investors
InvestorRounds
The Vertical GroupSeed, Series A
Sony Ventures CorporationSeed
U.S. Venture PartnersSeries A
ShangBay CapitalSeries A, Seed
Sony Innovation FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 28, 2025

    Partnered with Pokémon to bring hundreds of episodes to its platform.

  • Nov 11, 2022

    $5.7M round led by ShangBay Capital

Luminopia, Inc. Filings

Explore SEC and related filing metadata, where available.

Luminopia, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Luminopia, Inc.'s valuation, stock price, and market status.

Is Luminopia, Inc. a public or private company?

Luminopia, Inc. is a private company.

What is the current stock price of Luminopia, Inc.?

Luminopia, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Luminopia, Inc. worth (valuation)?

Valuation information for Luminopia, Inc. is not publicly available.

Can I buy Luminopia, Inc. stock?

Luminopia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Luminopia, Inc.'s last funding round?

Luminopia, Inc.'s most recent funding round was Series A on June 27, 2023.

Who are the main investors in Luminopia, Inc.?

Key investors in Luminopia, Inc. include U.S. Venture Partners, ShangBay Capital.

Will Luminopia, Inc. IPO soon?

No public IPO plans have been announced for Luminopia, Inc..

How can I track Luminopia, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luminopia, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range20
Year Founded2016
Last FundingJun 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?